{"patient_id": 110219, "patient_uid": "8361521-3", "PMID": 34394938, "file_path": "noncomm/PMC008xxxxxx/PMC8361521.xml", "title": "Apremilast monotherapy for palmoplantar pustulosis: Report of three cases", "patient": "Patient 3 was a 58-year-old man with a history of plaque type psoriasis and psoriatic arthritis ( right). He received multiple treatments such as topical corticosteroids (TCS), methotrexate, ustekinumab and adalimumab. When receiving adalimumab, arthritis was in remission; however, plaque on his left palm persisted. He was then lost to follow-up for 3 years. Later, he presented with erythema, scaling and numerous pustules on his left palm and third and forth finger of his right hand. Apremilast 30 mg bid was introduced, and partial response was observed after 3 months. After 9 months, new pustules were observed and arthritis got worse; therefore, treatment with apremilast was stopped. No adverse effects were reported. Selected patient characteristics are presented in .", "age": "[[58.0, 'year']]", "gender": "M", "relevant_articles": "{'28239890': 1, '26792812': 1, '33178709': 1, '32008176': 1, '34684041': 1, '31958161': 1, '29905386': 1, '29055155': 1, '34394938': 2}", "similar_patients": "{'8361521-1': 2, '8361521-2': 2}"}